Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Free Cash Flow (2016 - 2025)

Medifast (MED) has disclosed Free Cash Flow for 16 consecutive years, with -$6.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Free Cash Flow rose 8.34% year-over-year to -$6.6 million, compared with a TTM value of $1.2 million through Dec 2025, down 92.66%, and an annual FY2025 reading of $1.2 million, down 92.66% over the prior year.
  • Free Cash Flow was -$6.6 million for Q4 2025 at Medifast, down from $10.8 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at $61.9 million in Q1 2023 and bottomed at -$19.1 million in Q4 2021.
  • Average Free Cash Flow over 5 years is $19.9 million, with a median of $10.9 million recorded in 2024.
  • The sharpest move saw Free Cash Flow tumbled 207.24% in 2021, then skyrocketed 891.09% in 2022.
  • Year by year, Free Cash Flow stood at -$19.1 million in 2021, then surged by 323.63% to $42.7 million in 2022, then tumbled by 77.56% to $9.6 million in 2023, then plummeted by 175.52% to -$7.2 million in 2024, then grew by 8.34% to -$6.6 million in 2025.
  • Business Quant data shows Free Cash Flow for MED at -$6.6 million in Q4 2025, $10.8 million in Q3 2025, and -$4.8 million in Q2 2025.